Veterinary Antibiotics Market Revenue to Attain USD 6.97 Bn by 2033

17 Jul 2025

Share :

Table of Content

1. Veterinary Antibiotics Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Veterinary Antibiotics Market? 3. Segment Insights 4. Regional Insights 5. Veterinary Antibiotics Market Coverage 6. Veterinary Antibiotics Market Key Players

Veterinary Antibiotics Market Revenue and Trends 2025 to 2033

The global veterinary antibiotics market revenue was valued at USD 5.43 billion in 2025 and is expected to attain around USD 6.97 billion by 2033, growing at a CAGR of 3.18% during forecast period. This market is witnessing rapid growth due to the increasing prevalence of animal diseases and rising awareness of pet health and wellness.

What are the Major Factors Driving the Growth of the Veterinary Antibiotics Market?

The market for veterinary antibiotics is experiencing robust growth, fueled by the increasing global demand for animal protein, particularly meat and milk. The expansion of livestock production to meet this demand has also led to a greater need for adequate disease prevention and treatment measures. The rising incidence of zoonotic diseases has increased awareness of animal health, motivating both pet owners and commercial livestock farmers to seek veterinary care. Furthermore, advances in veterinary diagnostics and antibiotic formulations are driving overall market expansion. These innovations enable veterinarians to deliver more targeted and effective treatments for animals while also supporting protocols for antibiotic stewardship. The growing levels of pet ownership, especially in urban areas, also contribute to the consumption of antibiotics in companion animals.

Segment Insights

• By product type, the tetracyclines segment sustained its dominance in the market in 2024. This is primarily due to its proven efficacy in treating a range of bacterial infections in animals, making it a first-line treatment.
• By route of administration, the oral segment led the market in 2024 due to its ease of administration. Due to the increased healthcare costs, pet owners are seeking convenient drug delivery methods, making oral drugs the preferred option. Advances in drug formulations led to the increased efficacy of oral drugs, boosting their adoption.
• By animal type, the livestock segment continues to dominate the market. Due to the increased prevalence of bacterial infection among livestock animals, there is a high demand for novel antibiotics that help increase the quality of life of livestock and prevent disease spread.
• By mode of delivery, the prescription-based segment dominated the market with a major revenue share in 2024. Pet owners have become more conscious of their pet's health, encouraging them to opt for trusted medicines. This significantly boosts the adoption of prescription-based antibiotics.
• By end-user, the animal farms segment held the largest share of the market in 2024. This is mainly due to the increased animal farming, driven by the heightened demand for animal products.
• By distribution channel, the distributors/wholesalers segment dominated the market in 2024. This is mainly due to their critical role in the supply chain, ensuring the timely delivery and availability of antibiotics for end users.

Regional Insights

Asia Pacific sustained dominance in the veterinary antibiotics market while capturing the largest share in 2024. This is mainly due to government initiatives promoting animal welfare. There is high demand for animal protein, creating the need for antibiotics to maintain the productivity and health of animals. Rising livestock production, increasing awareness of animal health, and high prevalence of bacterial infection ensure the long-term growth of the market.

Meanwhile, North America is likely to grow at a notable rate in the upcoming period. This is mainly due to its well-established animal healthcare system and high awareness of animal diseases. The region has a high adoption rate of pet ownership. There is increasing spending on pet care, supporting regional market growth.

Veterinary Antibiotics Market Coverage

Recent Development

• In January 2023, Norbrook launched Tulieve®, a generic tulathromycin injectable for beef, cattle, and swine respiratory infections.
  (Source: https://www.norbrook.com)

Veterinary Antibiotics Market Key Players

• Zoetis Inc.
• Elanco Animal Health
• Merck Animal Health
• Boehringer Ingelheim Vetmedica
• Ceva Santé Animale
• Virbac
• Vetoquinol S.A.
• Phibro Animal Health Corporation
• Bayer Animal Health (Now part of Elanco)
• Norbrook Laboratories Ltd.
• Dechra Pharmaceuticals
• Neogen Corporation
• Zydus Animal Health
• Huvepharma
• Kyoritsu Seiyaku Corporation
• HIPRA S.A.
• Ourofino Saúde Animal
• ECO Animal Health
• ANI Pharmaceuticals (Animal Division)
• IDEXX Laboratories, Inc. (Diagnostics + Adjacent Antibiotic Offerings)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6408

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344